(Total Views: 390)
Posted On: 02/28/2020 2:36:16 PM
Post# of 72446
Email from IPIX just received:
Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
As conveyed across the last few weeks, Innovation has received inquiries asking about Brilacidin’s potential to treat the coronavirus (COVID-19) given the urgent worldwide need to find effective treatments for this deadly epidemic.
Please see attached as a PDF an informational overview summarizing the scientific rationale for Brilacidin as a potential coronavirus (COVID-19) treatment.
The Company will keep shareholders apprised of news related to evaluating Brilacidin’s antiviral properties for potentially treating COVID-19, and other viruses, in addition to its core Brilacidin programs, in Ulcerative Colitis and Oral Mucositis.
Download now
Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
As conveyed across the last few weeks, Innovation has received inquiries asking about Brilacidin’s potential to treat the coronavirus (COVID-19) given the urgent worldwide need to find effective treatments for this deadly epidemic.
Please see attached as a PDF an informational overview summarizing the scientific rationale for Brilacidin as a potential coronavirus (COVID-19) treatment.
The Company will keep shareholders apprised of news related to evaluating Brilacidin’s antiviral properties for potentially treating COVID-19, and other viruses, in addition to its core Brilacidin programs, in Ulcerative Colitis and Oral Mucositis.
Download now
(3)
(0)
